InsiderClue
Insiders · Profile

Sands Capital Life Sciences Pulse Fund II, L.P.

10% owner at Inhibikase Therapeutics. Filing since 21 Nov 2025. CIK 0001875620

Company
Date
Role
Action
Shares
Amount
Of holding
IKT Inhibikase Therapeutics, Inc.
21 Nov 2025
10% owner
Bought
2,068,965
$3.00M
18.9%
1 decision on file.